No over-the-counter product can reliably clear actinic keratoses the way prescription creams or in-office procedures do. The most effective OTC intervention is also the least glamorous: broad-spectrum sunscreen used daily, which in a randomized trial not only prevented new lesions but caused some existing ones to regress. Beyond sunscreen, oral nicotinamide (vitamin B3) has the strongest clinical evidence, reducing actinic keratosis counts by roughly 11 to 20 percent over a year in a large phase 3 trial. Other OTC options, from retinol serums to keratolytic peels to DNA repair enzyme lotions, occupy a supporting tier with more limited proof behind them. Understanding what each can and cannot do matters, because actinic keratoses sit on a spectrum that can lead to squamous cell carcinoma, and relying on weak treatments for something that needs medical attention is a genuine risk.
Why Actinic Keratoses Deserve Attention
Actinic keratoses are rough, scaly patches on sun-exposed skin caused by cumulative ultraviolet damage to skin-cell DNA. The damage often involves mutations in the p53 tumor suppressor gene, the same gene frequently mutated in squamous cell carcinoma (SCC).1British Journal of Dermatology. From actinic keratosis to squamous cell carcinoma That shared genetic damage is why dermatologists treat actinic keratoses as precancerous rather than merely cosmetic. Not every patch will progress to SCC, but there is no reliable way to predict which ones will, so the standard approach is to treat them all or at least monitor them closely.
Management is generally divided into lesion-directed approaches, like freezing individual spots with liquid nitrogen, and field-directed approaches that treat a broader area of sun-damaged skin at once with topical creams or light-based therapies.2PubMed Central. A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions Prescription field treatments like 5-fluorouracil (5-FU) and imiquimod have strong evidence behind them. OTC products cannot match those clearance rates, but they serve a different purpose: reducing new lesion formation, slowing progression, and maintaining skin between clinical treatments.
Sunscreen as an Active Treatment, Not Just Prevention
Most people think of sunscreen as prevention, but for actinic keratoses it functions as a mild treatment in its own right. A landmark randomized trial in Australia assigned over 400 people to daily sunscreen or a base cream with no UV filters. The sunscreen group developed fewer new lesions and had significantly more remissions of existing ones than the control group. The effect was dose-dependent: the more sunscreen people applied, the better both new-lesion prevention and existing-lesion regression became.3PubMed. Reduction of solar keratoses by regular sunscreen use
This makes daily broad-spectrum sunscreen (SPF 30 or higher, reapplied every two hours during sun exposure) the baseline OTC recommendation for anyone with actinic keratoses. It is cheap, widely available, and has the strongest randomized evidence of any non-prescription intervention. No other OTC product has been shown to cause existing actinic keratoses to regress in a controlled trial of that size. If you do nothing else over the counter, consistent sunscreen use is the single most impactful step you can take.
Oral Nicotinamide (Vitamin B3)
Nicotinamide, the amide form of vitamin B3, is a supplement you can buy at any pharmacy. It boosts cellular energy production and enhances DNA repair in skin cells after UV exposure.4PubMed Central. Mechanistic Insights into the Multiple Functions of Niacinamide: Therapeutic Implications and Cosmeceutical Applications in Functional Skincare Products That biological role prompted researchers to test whether it could prevent skin cancers and precancers in high-risk individuals.
The strongest evidence comes from a phase 3 randomized trial published in the New England Journal of Medicine. The study enrolled 386 people who had a history of at least two non-melanoma skin cancers in the previous five years. Those who took 500 mg of nicotinamide twice daily had 11 percent fewer actinic keratoses at three months, 14 percent fewer at six months, 20 percent fewer at nine months, and 13 percent fewer at 12 months compared to the placebo group. All of those differences were statistically significant.5PubMed. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention
A 13 to 20 percent reduction may not sound dramatic, and it isn’t if you compare it to prescription 5-FU, which can clear most visible lesions entirely. But for an inexpensive, well-tolerated supplement taken alongside sunscreen, that reduction adds up over years of use. The catch: the benefit disappeared after participants stopped taking it, so nicotinamide works only as long as you keep taking it. It is also worth noting this trial studied people at very high risk of skin cancer, not the general population with a couple of scattered keratoses. The effect size in lower-risk individuals is not established.
OTC Retinoids
Retinoids are vitamin A derivatives that speed up skin-cell turnover and have been studied in actinic keratosis for decades. Prescription-strength tretinoin (often 0.05 to 0.1 percent) has shown meaningful results. One large controlled study found tretinoin 0.1 percent applied twice daily produced excellent responses in about 73 percent of patients, and a separate trial showed tretinoin 0.05 percent reduced keratoses by roughly 45 percent compared to 23 percent in the placebo group.6Anais Brasileiros de Dermatologia. Retinoids for prevention and treatment of actinic keratosis
The problem for the OTC shopper is that these results come from prescription-strength formulations. The retinoids available without a prescription, mainly retinol and adapalene 0.1 percent, are considerably weaker. Retinol must be converted by your skin into retinoic acid (the active form), and only a fraction survives that conversion. Adapalene, while available OTC for acne, has not been studied specifically for actinic keratosis clearance. So while the mechanism is plausible and the prescription data are encouraging, the evidence does not directly support OTC retinoids as a reliable keratosis treatment. They are better framed as long-term skin-maintenance ingredients that may slow photoaging and new lesion development rather than active clearance agents.
Keratolytic Agents Like Salicylic Acid and Glycolic Acid
Keratolytics dissolve the outer layer of thickened, scaly skin. Salicylic acid and glycolic acid are the most accessible OTC options. Salicylic acid is sometimes used as a preliminary step to remove the overlying keratin buildup on thickened keratoses, making the underlying abnormal cells more accessible to other treatments. Glycolic acid promotes keratolysis and stimulates collagen repair, and both have been discussed as useful adjuncts in keratosis management strategies.7PubMed Central. Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial
In practice, OTC products containing these acids at typical cosmetic concentrations (salicylic acid up to 2 percent, glycolic acid up to about 10 percent) will soften and flatten rough patches but are unlikely to resolve the underlying abnormal cell growth. Higher concentrations used in chemical peels can be more effective but are generally administered in a clinical setting. Think of OTC keratolytics as grooming tools for textured, scaly skin rather than treatments for the precancerous process itself. They can make keratoses less noticeable and less rough, which many people find worthwhile, but they do not address the DNA damage underneath.
DNA Repair Enzyme Creams
A newer and somewhat niche category of OTC skincare involves topical products containing DNA repair enzymes, most commonly photolyase and endonuclease. The idea is to help skin cells fix UV-induced DNA damage that would otherwise accumulate and drive keratosis formation. A review of the available literature concluded that topical DNA repair enzymes do enhance the removal of DNA damage, reduce the appearance of new actinic keratoses, and increase the regression of existing ones.8PubMed Central. Six critical questions for DNA repair enzymes in skincare products: a review in dialog
These products are available without a prescription, often marketed under dermatology-adjacent brands and typically paired with sunscreen. The evidence base is smaller than for sunscreen or nicotinamide, and most studies have been modest in size. Still, the biological rationale is sound, and the data that exist point in a positive direction. If you already use sunscreen daily and take nicotinamide, a DNA repair enzyme product is a reasonable addition rather than a replacement. Expect to pay significantly more than you would for standard sunscreen, since these are specialty formulations.
Polypodium Leucotomos Extract
Polypodium leucotomos is a tropical fern whose extract is sold as an oral supplement, often marketed as an internal sunscreen. It works by bolstering the skin’s own antioxidant defenses against UV radiation, neutralizing reactive oxygen species and free radicals generated by sun exposure, and reducing inflammation and cell damage.9PubMed Central. Clinical Applications of Polypodium leucotomos (Fernblock ®): An Update In a controlled trial, subjects taking 240 mg twice daily for 60 days showed a greater increase in their minimal erythema dose, meaning their skin tolerated more UV before burning, and had less UV-induced redness compared to placebo.10PubMed Central. Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects
The catch is that polypodium leucotomos has mostly been studied for its photoprotective effects rather than directly for actinic keratosis reduction. There is a logical chain: less UV damage should mean fewer keratoses over time, but a direct trial measuring keratosis counts the way the nicotinamide trial did is lacking. It is better understood as a supplementary photoprotective strategy than as a keratosis treatment. And it is not a substitute for topical sunscreen. Think of it as an extra layer of defense for people who are already doing everything else and want to push the odds further in their favor.
Botanical Extracts and Other Natural Topicals
A handful of plant-derived compounds have attracted research interest for actinic keratosis. Birch bark extract contains betulinic acid and related compounds that can induce abnormal cells to self-destruct (apoptosis) and reduce inflammation. A pilot study explored birch bark extract for keratosis treatment and found the rationale promising, though pilot data are preliminary by definition and the sample sizes have been small.11PubMed. Treatment of actinic keratoses with birch bark extract: a pilot study
Green tea polyphenols, curcumin, and various other botanical extracts appear in OTC serums and creams marketed for sun-damaged skin. Most have laboratory data showing anti-inflammatory or antioxidant properties, but controlled clinical trials specifically measuring actinic keratosis outcomes are scarce. The evidence is too thin to recommend any specific botanical extract as a standalone keratosis treatment. If a product interests you, look for whether it has been tested in a human trial for keratosis specifically, not just in cell cultures or for general skin aging.
How OTC Options Compare to Prescription Treatments
To put OTC products in perspective, it helps to understand how effective the prescription alternatives are. A systematic review and network meta-analysis compared the odds of complete clearance across major prescription treatments for actinic keratosis of the face and scalp. Compared to placebo, 5-FU 5 percent had roughly 35 times the odds of clearing all lesions, 5-FU 4 percent had about 30 times the odds, and photodynamic therapy with aminolevulinic acid had about 24 times the odds. Even the newer agent tirbanibulin 1 percent achieved about 11 times the odds of clearance over placebo.12PubMed Central. Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials These are clearance rates that no OTC product comes close to matching.
The gap matters for your decision-making. If you have one or two thin, barely palpable keratoses and your dermatologist is monitoring them, an OTC strategy of sunscreen, nicotinamide, and perhaps a retinol or DNA repair product is a reasonable maintenance plan. If you have thick, crusty, or rapidly growing spots, or if you have many keratoses across a wide area of sun-damaged skin, OTC products alone are not adequate. Those situations call for prescription field therapy or in-office procedures.
Adherence Matters More Than the Product You Pick
One underappreciated factor in actinic keratosis management is that even prescription topicals have poor adherence rates. Treatment duration, the severity of local skin reactions like redness and peeling, and confusion over complex application schedules all contribute to people quitting early.13PubMed. Adherence to topical therapies in actinic keratosis: A literature review If patients struggle to complete a four-week course of prescription 5-FU, expecting them to maintain a daily OTC routine for months or years is optimistic. The “best” OTC treatment is ultimately the one you will actually use consistently. A sunscreen that stays in your medicine cabinet is worse than a cheaper one you apply every morning.
This is where the simplicity of the nicotinamide recommendation shines. Taking a pill twice a day is easier to sustain than applying multiple specialty creams. Combining it with a sunscreen you already like and use is about as low-friction as a skin-health regimen gets. Adding a retinol serum or a DNA repair product at night is a modest extra step that some people will maintain and others will not. Be honest with yourself about what you will do for years, not just weeks.
The Cost Question
Actinic keratosis management in the United States is expensive at the system level, with direct costs estimated at around $1.2 billion per year, driven primarily by physician office visits and procedures.14PubMed. Pharmacoeconomic considerations in treating actinic keratosis For individual patients, this translates to copays for dermatology visits, costs of cryotherapy sessions, and prescription cream prices that can range from modest to several hundred dollars depending on insurance coverage.
OTC products are generally cheaper per unit but add up over time because they are used indefinitely. A bottle of nicotinamide 500 mg costs a few dollars a month. Daily sunscreen runs anywhere from a few dollars to much more depending on the brand. DNA repair enzyme products and premium retinol serums can cost $30 to $80 per bottle. The total OTC spend over a year is often comparable to a single dermatology visit with cryotherapy, which is one reason some patients gravitate toward OTC options even when clinical treatment would be more appropriate. The math works only if the OTC approach is actually adequate for the severity of your keratoses.
When to Stop Relying on OTC Products
Certain signs mean an actinic keratosis needs professional evaluation, not more over-the-counter cream. A lesion that is growing rapidly, bleeding, becoming thickened or nodular, or developing on a base of significantly sun-damaged skin with many surrounding keratoses warrants a dermatologist visit. Specific dermatoscopic features like certain vessel patterns and white structureless areas can help clinicians distinguish an early squamous cell carcinoma from a benign keratosis.15Journal of the American Academy of Dermatology. Evaluation of dermatoscopic criteria for early detection of squamous cell carcinoma arising on an actinic keratosis These distinctions are beyond what you can assess at home, even with good lighting and a magnifying mirror.
Smartphone apps using artificial intelligence have been explored for triaging skin lesions at home. A pilot study found that in some cases the app flagged actinic keratoses as high risk and prompted more aggressive follow-up than a general practitioner would have initiated on their own.16PubMed Central. Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study These tools are still in early stages and should not replace professional evaluation, but they may be useful for prompting a visit you might otherwise delay. The broader point is that OTC management is a complement to dermatologic care, never a replacement for it. If you have been diagnosed with actinic keratoses, you should be seeing a dermatologist at regular intervals regardless of what products you use at home.
Putting an OTC Regimen Together
If your dermatologist has confirmed that your keratoses are mild and appropriate for a watch-and-maintain approach, a practical OTC regimen looks something like this:
- Daily sunscreen: Broad-spectrum SPF 30 or higher, applied to all sun-exposed skin every morning and reapplied during prolonged outdoor time. This is the non-negotiable foundation.
- Nicotinamide 500 mg twice daily: The best-supported OTC supplement for reducing new keratosis formation. Inexpensive and well tolerated.
- A retinol or adapalene product at night: Optional, with indirect evidence supporting the mechanism. Start with a low concentration to minimize irritation.
- A DNA repair enzyme cream or serum: Optional and costlier, but the data lean positive. Often combined with sunscreen in the same product.
None of these products will make a thick, established keratosis disappear. They work by shifting the odds over months and years: fewer new lesions developing, existing thin ones more likely to regress on their own, and less cumulative DNA damage accumulating with each day of sun exposure. For people with extensive sun damage or a history of skin cancer, these OTC measures belong alongside professional treatment, not instead of it. For people with occasional mild keratoses who are already under dermatologic surveillance, they are a reasonable way to slow down the conveyor belt between dermatology appointments.